SCHEMBL7549825

SCHEMBL7549825

COc1ccc(-c2cncc(-c3cn(CCCN(C)C)c4cccnc34)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.51
GSK3B P49841 6/20 0.45
PDE10A Q9Y233 2/20 0.39
QPCT Q16769 2/20 0.39
HTR6 P50406 2/20 0.38
FLT3 P36888 1/20 0.38
PRKD1 Q15139 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAOB P27338 1/20 0.38
BRD9 Q9H8M2 1/20 0.38
BRD7 Q9NPI1 1/20 0.38
PRKACA P17612 1/20 0.36
PRKACG P22612 1/20 0.36
PRKACB P22694 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
FYN P06241 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7547677 0.91 KDR (0.49) KDRGSK3BQPCTHTR6FLT3
SCHEMBL7548397 0.89 KDR (0.57) KDRGSK3BHTR6TDP1PRKACA
SCHEMBL7548728 0.88 KDR (0.52) KDRGSK3BPDE10AHTR6PRKACA
SCHEMBL7549158 0.85 KDR (0.69) KDRGSK3BQPCTHTR6FLT3
SCHEMBL7551398 0.84 KDR (0.54) KDRGSK3BPDE10AQPCT
SCHEMBL7986889 0.84 KDR (0.51) KDRGSK3BQPCT
SCHEMBL7549028 0.83 KDR (0.52) KDRPDE10AMAOBBRD9BRD7
SCHEMBL7976532 0.83 KDR (0.51) KDRGSK3BHTR6FYN
SCHEMBL7508695 0.83 KDR (0.74) KDRGSK3BHTR6MAOB
SCHEMBL7990876 0.82 KDR (0.56) KDRGSK3BQPCTHTR6FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed